Prehospital use of APSAC: Results of a placebo-controlled study

https://doi.org/10.1016/0002-9149(89)90927-2Get rights and content

Abstract

Thrombolytic treatment efficacy is greater when the delay between onset of pain and treatment is short. To give treatment before admission to a coronary care unit, responsibility needs to be transferred from cardiologists to other physicians working in mobile care units. We conducted a 2-part feasibility study to investigate this strategy. Part 1 evaluated the diagnostic accuracy of mobile care unit physicians. Results from this study indicate that with regard to the diagnosis of acute myocardial infarction, the risk of a wrong diagnosis is low. Part 2 was a placebo-controlled trial involving 100 patients in which 57 received anisoylated plasminogen streptokinase activator complex (APSAC) (30 U) at home and 43 received placebo at home. Patients receiving placebo at home were reevaluated on arrival in a coronary care unit and received APSAC (30 U) if indicated. The main results were that (1) diagnostic accuracy was good—all patients had an acute coronary syndrome and 97 of 100 patients had myocardial infarction; (2) time gain was approximately 60 minutes; (3) coronary patency rate was 72%; (4) ejection fraction was higher in the prehospital group (56.7%) than in the control group (53.4%), but the difference was not significant; (5) there was no rhythmic or bleeding complication related to the prehospital treatment; (6) 5 patients died from cardiogenic shock—2 between home and hospital and 3 in the hospital (3 received thrombolytic treatment at home and 2 received placebo at home and APSAC in the hospital); and (7) prehospital administration of APSAC did not induce a delay in arrival to the coronary care unit.

Data indicate that prehospital thrombolysis with APSAC is both feasible and safe if the mobile care unit team is specifically trained. In terms of mortality, the efficacy of prehospital thrombolysis needs to be demonstrated. To determine this, the European Myocardial Infarction Project is currently under way.

References (7)

There are more references available in the full text version of this article.

Cited by (117)

  • European Resuscitation Council Guidelines for Resuscitation 2015 Section 8. Initial management of acute coronary syndromes

    2015, Resuscitation
    Citation Excerpt :

    Fibrinolysis is effective specifically in the first 2 to 3 h after symptom onset; PPCI is less time sensitive. A meta-analysis of 3 RCTs including 531 patients showed benefit of prehospital versus inhospital fibrinolysis in terms of survival to hospital discharge without evidence of additional harm in terms of major or intracranial bleeding.123–125 An effective and safe system for out-of-hospital fibrinolytic therapy requires adequate facilities for the diagnosis and treatment of STEMI and its complications.

  • Part 5: Acute coronary syndromes. 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations

    2015, Resuscitation
    Citation Excerpt :

    For the critical outcome of intracranial hemorrhage, we have identified low-quality evidence (downgraded for risk of bias and imprecision) from 2 RCTs74,75 enrolling 438 patients showing no additional harm from prehospital fibrinolysis compared with in-hospital fibrinolysis (OR, 2.14; 95% CI, 0.39–11.84). For the important outcome of bleeding, we have identified low-quality evidence (downgraded for imprecision) from 2 RCTS74,75 enrolling 438 patients showing no additional harm from prehospital fibrinolysis compared with in-hospital fibrinolysis (OR, 0.96; 95% CI, 0.40–2.32). For other outcomes (revascularization, reinfarction, and ischemic stroke), no evidence from RCTs was found.

  • Part 9: Acute coronary syndromes: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations

    2010, Resuscitation
    Citation Excerpt :

    In patients with STEMI in the prehospital setting, does the use of prehospital fibrinolytics, compared with in-hospital fibrinolytics, improve outcomes (e.g., chest pain resolution, infarct size, ECG resolution, survival to discharge, 30/60 days mortality)? Nineteen studies demonstrated significantly reduced time to treatment when fibrinolytics were given to patients with STEMI in the prehospital setting by either physicians, nurses, or paramedics (LOE 1496,497,498,499–501 LOE 2124,502–510; LOE 3511–513). Eleven studies showed that a greater proportion of the patients treated with prehospital fibrinolysis had shorter duration and increased frequency of total resolution of chest pain by the time of admission, ECG resolution, and decreased mortality (LOE 1496,499,500,514–516; LOE 2505,506,508,511,513).

  • Acute ST-segment elevation myocardial infarction: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)

    2008, Chest
    Citation Excerpt :

    Another nonrandomized, observational study48 in 6,891 patients ≥ 75 years old with first registry-recorded STE MI also confirm an overall survival advantage to fibrinolysis in the elderly. Several randomized trials49–54 of prehospital- initiated fibrinolysis have provided important insights regarding the impact of early treatment (Tables 4, 5). Indeed, acquisition of 12-lead ECGs in the field and the use of a reperfusion checklist (Fig 1)6 could lead to more rapid prehospital and hospital care.54,55

  • The Role of Fibrinolytics in the Prehospital Treatment of ST-Elevation Myocardial Infarction (STEMI)

    2008, Journal of Emergency Medicine
    Citation Excerpt :

    This strategy has been shown to improve clinical outcome and reduce mortality, and is feasible in rural and urban locations. It should be noted that many of the studies that demonstrate benefits with prehospital fibrinolysis (as shown in Table 1) were conducted in Europe and Israel, where a physician was included in the ambulance personnel, which is not usual practice in the United States (15–21,26,27). However, the two North American studies and one Swedish study in which prehospital fibrinolysis was administered by paramedics also showed improvements in time to treatment initiation, with comparable or better outcomes compared with in-hospital treatment (24,29,30).

View all citing articles on Scopus
View full text